PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity

Tianbai Zhong(Tsinghua University), Wei Wu(Heilongjiang University), Yu Li(Tsinghua University), Xin Lin(Central South University), Xiuyun Sun(Center for Life Sciences), Yongbo Liu(Henry Ford Health System), Yu Rao(Zhengzhou University)
Signal Transduction and Targeted Therapy
May 26, 2022
10.1038/s41392-022-00970-8
Cited by 4

Related Papers

Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|605
RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to Tumors
|ACS Nano|2013|364
Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer
|ACS Nano|2013|270
Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging
|Nano Letters|2011|263